查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2041806

畜牧益生菌市場預測－全球按類型、劑型、原料、配方、畜種、認證、應用、最終用戶和地區分類的分析——2034年

Direct-Fed Microbials Market Forecasts to 2034 - Global Analysis By Type, Form, Source, Formulation, Livestock, Certification, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球畜牧殺菌劑（DFM）市場預計到 2026 年將達到 20.8 億美元，在預測期內以 8.8% 的複合年成長率成長，到 2034 年將達到 40.9 億美元。

直接飼餵微生物（DFM），也稱為動物益生菌，是指活的微生物（細菌或酵母），當以適當劑量飼餵時，能為宿主動物帶來健康益處。 DFM廣泛應用於畜禽養殖業，能夠平衡腸道菌叢，促進消化、營養吸收和免疫系統功能。這些微生物可以抑制有害病原體，改善腸道整體健康。補充DFM被認為可以提高動物的飼料轉換率、生長速度和抗病能力。

根據美國國家生物技術資訊中心 (NCBI) 的數據，益生菌在禽類養殖中的應用正以 7.7% 的複合年成長率逐步擴大，預計到 2025 年將達到 1.25 億美元，這主要得益於人們對無抗生素禽肉的需求不斷成長以及益生菌功效得到充分研究。

對畜產品的需求不斷成長

隨著世界人口的成長，對動物性產品的需求日益增加，推動了畜牧業的擴張。植物微生物製劑（DFM）因其增強動物營養和健康的作用而備受青睞，正逐漸被市場接受以滿足這一需求。養殖戶正在飼料中添加DFM補充劑，以提高飼料轉換率、促進生長並緩解動物壓力反應。這一趨勢正在推動畜牧管理領域DFM市場的擴張。

保存期限和穩定性方面的限制

直接飼餵微生物製劑（DFM）通常受溫度、濕度和環境條件等因素的影響，保存期限和穩定性有限。這些限制因素為維持產品中微生物的長期活性帶來了挑戰。較短的保存期限需要頻繁更換產品，導致生產成本增加和分銷管道受限，從而阻礙市場成長。

人們越來越關注動物營養

畜牧和寵物飼主對均衡飲食重要性的認知不斷提高，推動了對直接飼餵微生物（DFM）產品的需求。這些微生物因其促進腸道健康和改善營養吸收的能力而備受關注。人們越來越傾向於採用預防性的動物營養管理和護理方法，這在飼料中DFM的日益普及中得到了清晰的體現，也凸顯了市場動態向更加重視動物整體健康的轉變。

與抗生素的競爭

家用殺菌劑（DFM）面臨來自抗生素的重大威脅，因為在畜禽養殖業中，它們經常被誤認為是抗生素。作為傳統的生長促進劑，抗生素可能會勝過家用殺菌劑產品，導致其市場佔有率下降。對抗生素抗藥性的擔憂進一步加劇了這種競爭，因為監管措施可能會優先考慮抗生素替代品。因此，這阻礙了市場成長。

新型冠狀病毒（COVID-19）的影響

新冠疫情透過供應鏈中斷、生產中斷和消費者優先事項的轉變，對直接飼用微生物製劑（DFM）市場造成了衝擊。封鎖措施和經濟的不確定性為農業和畜牧業中DFM產品的分銷和推廣帶來了挑戰。然而，隨著人們對動物健康和免疫力重要性的認知不斷提高，疫情後時代，農民和生產者尋求改善牲畜福利的解決方案，這可能會推動未來對DFM的需求成長。

在預測期內，家禽業預計將成為最大的細分市場。

由於消化功能、營養吸收和免疫功能的改善，家禽養殖業預計將迎來顯著成長。直接飼餵微生物（DFM）透過改善腸道健康和提高整體生產力，在家禽養殖中發揮至關重要的作用。這些有益微生物通常由益生菌（如細菌和酵母）組成，能夠平衡雞隻的腸道菌叢。此外，它們的使用符合永續的、無抗生素的養殖方式，從而確保雞群更健康，並提高家禽生產效率。

預計在預測期內，壓力管理細分市場將呈現最高的複合年成長率。

預計在預測期內，壓力管理領域將呈現最高的複合年成長率。直接飼餵微生物（DFM）是一種富含益生菌和酵母的補充劑，這些益生菌和酵母因其在壓力管理方面的潛在功效而聞名。 DFM透過促進健康的腸道菌叢，有助於改善營養吸收和免疫功能，而這些都是減輕壓力的關鍵因素。這些微生物也有助於維持消化器官系統的平衡，積極影響神經傳導物質的產生，並降低皮質醇水平。

市佔率最大的地區：

預計在預測期內，亞太地區將佔據最大的市場佔有率，這主要得益於畜產品需求的成長和人們對動物健康意識的提高。人口快速成長、可支配收入增加以及對高品質畜產品的偏好等因素正在推動市場擴張。此外，政府推行的促進永續農業實踐的舉措也對亞太地區市場的強勁表現起到了積極作用。

複合年成長率最高的地區：

由於人們越來越意識到腸道健康對畜禽的重要性，預計歐洲在預測期內將呈現最高的複合年成長率。除了對天然和永續動物營養解決方案的需求不斷成長外，畜牧業中抗生素使用的嚴格監管也進一步推動了市場擴張。此外，歐洲直接食用動物市場也反映了畜牧業向更健康、更環保的養殖方式轉變，凸顯了該地區對永續農業的承諾。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球畜牧益生菌市場：依類型分類

  • 乳酸菌（LAB）
  • 枯草桿菌
  • 雙歧桿菌
  • 鏈球菌
  • 腸球菌
  • 片球菌
  • Saccharomyces cerevisiae
  • 丙酸桿菌
  • 其他類型

第6章 全球畜牧益生菌市場：依形式分類

  • 粉末
  • 液體
  • 膠囊
  • 其他形式

第7章 全球畜牧益生菌市場：依來源分類

  • 自然的
  • 合成

第8章 全球畜牧益生菌市場：依配方分類

  • 膠囊製劑
  • 塗料配方
  • 混合配方
  • 發酵製劑
  • 穩定製劑
  • 其他準備工作

第9章 全球畜牧真菌市場：依動物種類分類

  • 反芻動物
    • 牛
    • 羊
    • 山羊
  • 家禽
    • 雞
    • 鴨子
    • 火雞
  • 豬
  • 水產養殖
    • 魚
    • 蝦
  • 寵物
    • 狗
    • 貓
  • 馬
  • 兔子
  • 其他牲畜

第10章 全球畜牧益生菌市場：依應用領域分類

  • 壓力管理
  • 抗生素替代品
  • 體重增加
  • 免疫功能
  • 病原體性行為感染
  • 纖維消化
  • 其他用途

第11章 全球畜牧益生菌市場：依最終用戶分類

  • 農民
  • 寵物飼主
  • 野生動物復健中心
  • 動物診所
  • 其他最終用戶

第12章 全球畜牧益生菌市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第13章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第14章：公司簡介

  • Chr. Hansen Holding A/S
  • Lallemand Inc.
  • Koninklijke DSM NV
  • Novozymes A/S
  • Microba Life Sciences
  • Archer Daniels Midland Company（ADM）
  • Kemin Industries Inc.
  • DuPont de Nemours Inc.
  • Cargill Incorporated
  • Evonik Industries AG
  • Alltech Inc.
  • Calpis Limited
  • Phibro Animal Health
  • Biomin Holding GmbH
  • Bayer AG
  • Probi AB
  • Novus International
  • Sabinsa Corporation
  • Kerry Group
  • Unique Biotech Limited
Product Code: SMRC24871

According to Stratistics MRC, the Global Direct-Fed Microbials (DFM) Market is accounted for $2.08 billion in 2026 and is expected to reach $4.09 billion by 2034 growing at a CAGR of 8.8% during the forecast period. Direct-Fed Microbials (DFMs), also known as probiotics for animals, refer to live microorganisms (bacteria or yeast) that can confer health benefits to the host animal when administered in adequate amounts. Widely used in livestock and poultry production, DFM promote a balanced gut microbiota, aiding in digestion, nutrient absorption, and immune system function. These microorganisms can outcompete harmful pathogens, enhancing overall gut health. DFM supplementation is believed to improve feed efficiency, growth rates, and disease resistance in animals.

According to The National Center for Biotechnology Information (NCBI), because of the rising demand for antibiotic-free poultry and its well-researched benefits, the use of probiotics in poultry has progressively expanded at a compound annual growth rate of 7.7%, over time, which is expected to reach 125 million USD by 2025.

Market Dynamics:

Driver:

Growing demand for livestock products

With a rising global population, there is a heightened need for animal-derived goods, prompting greater livestock production. Direct-Fed Microbials, known for enhancing animal nutrition and health, are gaining popularity in response to this demand. Farmers are adopting DFM supplements to boost feed efficiency, stimulate growth, and address stressors in animals. This trend is fueling the expansion of the DFM market within the livestock management sector.

Restraint:

Limited shelf life & stability

Direct-fed microbials (DFMs) often have limited shelf life and stability due to factors like temperature sensitivity, moisture, and susceptibility to environmental conditions. This limitation poses challenges in maintaining the viability of microorganisms in the product over time. The reduced shelf life hampers market growth as it necessitates frequent product turnover, increasing production costs and limiting distribution options.

Opportunity:

Rising awareness of animal nutrition

The heightened awareness among livestock and pet owners regarding the significance of well-balanced diets is boosting the demand for DFM products. These microbials are gaining prominence for their ability to support gut health and improve nutrient absorption. The growing preference for proactive approaches to animal nutrition and care is evident in the rising adoption of DFM in animal feed, underscoring a broader shift in the market dynamics towards holistic animal well-being.

Threat:

Competition from antibiotics

The direct-fed microbials (DFM) faces a significant hazard from antibiotics as they are often used interchangeably in livestock and poultry farming. Antibiotics, being traditional growth promoters, may overshadow the demand for DFM products, leading to a decline in market share. Concerns over antibiotic resistance further intensify this competition, as regulatory measures may prioritize antibiotic alternatives. Therefore, this aspect hampers the market growth.

Covid-19 Impact

The covid-19 pandemic has influenced the direct-fed microbials (DFM) market by disrupting supply chains, impacting production, and altering consumer priorities. Lockdown measures and economic uncertainties have led to challenges in the distribution and adoption of DFM products in the agricultural and livestock sectors. However, increased awareness of the importance of animal health and immunity may drive future demand for DFM as farmers and producers seek solutions to enhance the well-being of livestock in the aftermath of the pandemic.

The poultry segment is expected to be the largest during the forecast period

The poultry segment is estimated to have a lucrative growth, due to improved digestion, nutrient absorption, and immune function. Direct-Fed Microbials (DFMs) play a crucial role in poultry farming by enhancing gut health and overall performance. These beneficial microorganisms, often comprising probiotics like bacteria and yeast, promote a balanced gut microbiota in chickens. Further, their use aligns with sustainable and antibiotic-free practices, ensuring healthier flocks and higher productivity in poultry production.

The stress management segment is expected to have the highest CAGR during the forecast period

The stress management segment is anticipated to witness the highest CAGR growth during the forecast period. Direct-Fed Microbials (DFMs) are beneficial bacteria and yeast supplements known for their potential in stress management. By promoting a healthy gut microbiota, DFMs contribute to improved nutrient absorption and immune function, crucial factors in mitigating stress. These microorganisms also aid in maintaining a balanced digestive system, positively influencing neurotransmitter production and reducing cortical levels.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing demand for livestock products and a growing awareness of animal health. Factors such as a burgeoning population, rising disposable income, and a shift towards quality animal products are driving market expansion. Additionally, government initiatives promoting sustainable agriculture practices contribute to the market's positive trajectory in the Asia Pacific region.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to increasing awareness of the importance of gut health in livestock and poultry. Rising demand for natural and sustainable animal nutrition solutions, coupled with stringent regulations on antibiotic use in animal farming, further fuels market expansion. Also, the European DFM market reflects a shift towards healthier and more eco-friendly livestock practices, emphasizing the region's commitment to sustainable agriculture.

Key players in the market

Some of the key players profiled in the Direct-Fed Microbials (DFM) Market include Chr. Hansen Holding A/S, Lallemand Inc., Koninklijke DSM N.V., Novozymes A/S, Microba Life Sciences, Archer Daniels Midland Company (ADM), Kemin Industries Inc., DuPont de Nemours Inc., Cargill Incorporated, Evonik Industries AG, Alltech Inc., Calpis Limited, Phibro Animal Health, Biomin Holding GmbH, Bayer AG, Probi AB, Novus International, Sabinsa Corporation, Kerry Group and Unique Biotech Limited.

Key Developments:

In June 2023, Kerry, a world leader in taste and nutrition, has launched its next generation Tastesense(TM) Advanced range of solutions, aimed at transforming the low and zero-sugar product market with an exceptional ability to deliver unparalleled sweetness and full-bodied mouthfeel, as well as sustainability benefits.

In April 2023, Microba Life Sciences entered into a new partnership with Aviwell, an agrifood data and life science technology company to combine Microba's world leading technology and experience in metagenomics and precision microbiome measurement with Aviwell's extensive capabilities in microbiome multi-omics analyses, bioinformatics, microbial isolation and culture, and in-vivo field applications.

In February 2019, Phibro, the New Jersey-based animal health company expanded its product line into direct-fed microbial sector. The goal of creating a direct-fed microbial was to improve the support provided to producers intent upon reducing their use of antimicrobials.

Types Covered:

  • Lactic Acid Bacteria (LAB)
  • Bacillus Subtilis
  • Bifidobacterium
  • Streptococcus
  • Enterococcus
  • Pediococcus
  • Saccharomyces Cerevisiae
  • Propionibacterium
  • Other Types

Forms Covered:

  • Powder
  • Liquid
  • Capsule
  • Other Forms

Sources Covered:

  • Natural
  • Synthetic

Formulations Covered:

  • Encapsulated Formulation
  • Coated Formulation
  • Blended Formulation
  • Fermented Formulation
  • Stabilized Formulation
  • Other Formulations

Livestocks Covered:

  • Ruminants
  • Poultry
  • Swine
  • Aquaculture
  • Pets
  • Horses
  • Rabbits
  • Other Livestocks

Applications Covered:

  • Stress Management
  • Antibiotic Alternatives
  • Weight Gain
  • Immune Function
  • Pathogenic Infections
  • Fiber Digestion
  • Other Applications

End Users Covered:

  • Farmers
  • Pet Owners
  • Wildlife Rehabilitation Centers
  • Veterinary Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Direct-Fed Microbials (DFM) Market, By Type

  • 5.1 Introduction
  • 5.2 Lactic Acid Bacteria (LAB)
  • 5.3 Bacillus Subtilis
  • 5.4 Bifidobacterium
  • 5.5 Streptococcus
  • 5.6 Enterococcus
  • 5.7 Pediococcus
  • 5.8 Saccharomyces Cerevisiae
  • 5.9 Propionibacterium
  • 5.10 Other Types

6 Global Direct-Fed Microbials (DFM) Market, By Form

  • 6.1 Introduction
  • 6.2 Powder
  • 6.3 Liquid
  • 6.4 Capsule
  • 6.5 Other Forms

7 Global Direct-Fed Microbials (DFM) Market, By Source

  • 7.1 Introduction
  • 7.2 Natural
  • 7.3 Synthetic

8 Global Direct-Fed Microbials (DFM) Market, By Formulation

  • 8.1 Introduction
  • 8.2 Encapsulated Formulation
  • 8.3 Coated Formulation
  • 8.4 Blended Formulation
  • 8.5 Fermented Formulation
  • 8.6 Stabilized Formulation
  • 8.7 Other Formulations

9 Global Direct-Fed Microbials (DFM) Market, By Livestock

  • 9.1 Introduction
  • 9.2 Ruminants
    • 9.2.1 Cattle
    • 9.2.2 Sheep
    • 9.2.3 Goats
  • 9.3 Poultry
    • 9.3.1 Chickens
    • 9.3.2 Ducks
    • 9.3.3 Turkeys
  • 9.4 Swine
  • 9.5 Aquaculture
    • 9.5.1 Fish
    • 9.5.2 Shrimp
  • 9.6 Pets
    • 9.6.1 Dogs
    • 9.6.2 Cats
  • 9.7 Horses
  • 9.8 Rabbits
  • 9.9 Other Livestocks

10 Global Direct-Fed Microbials (DFM) Market, By Application

  • 10.1 Introduction
  • 10.2 Stress Management
  • 10.3 Antibiotic Alternatives
  • 10.4 Weight Gain
  • 10.5 Immune Function
  • 10.6 Pathogenic Infections
  • 10.7 Fiber Digestion
  • 10.8 Other Applications

11 Global Direct-Fed Microbials (DFM) Market, By End User

  • 11.1 Introduction
  • 11.2 Farmers
  • 11.3 Pet Owners
  • 11.4 Wildlife Rehabilitation Centers
  • 11.5 Veterinary Clinics
  • 11.6 Other End Users

12 Global Direct-Fed Microbials (DFM) Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Chr. Hansen Holding A/S
  • 14.2 Lallemand Inc.
  • 14.3 Koninklijke DSM N.V.
  • 14.4 Novozymes A/S
  • 14.5 Microba Life Sciences
  • 14.6 Archer Daniels Midland Company (ADM)
  • 14.7 Kemin Industries Inc.
  • 14.8 DuPont de Nemours Inc.
  • 14.9 Cargill Incorporated
  • 14.10 Evonik Industries AG
  • 14.11 Alltech Inc.
  • 14.12 Calpis Limited
  • 14.13 Phibro Animal Health
  • 14.14 Biomin Holding GmbH
  • 14.15 Bayer AG
  • 14.16 Probi AB
  • 14.17 Novus International
  • 14.18 Sabinsa Corporation
  • 14.19 Kerry Group
  • 14.20 Unique Biotech Limited

List of Tables

  • Table 1 Global Direct-Fed Microbials (DFM) Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Direct-Fed Microbials (DFM) Market Outlook, By Type (2023-2034) ($MN)
  • Table 3 Global Direct-Fed Microbials (DFM) Market Outlook, By Lactic Acid Bacteria (LAB) (2023-2034) ($MN)
  • Table 4 Global Direct-Fed Microbials (DFM) Market Outlook, By Bacillus Subtilis (2023-2034) ($MN)
  • Table 5 Global Direct-Fed Microbials (DFM) Market Outlook, By Bifidobacterium (2023-2034) ($MN)
  • Table 6 Global Direct-Fed Microbials (DFM) Market Outlook, By Streptococcus (2023-2034) ($MN)
  • Table 7 Global Direct-Fed Microbials (DFM) Market Outlook, By Enterococcus (2023-2034) ($MN)
  • Table 8 Global Direct-Fed Microbials (DFM) Market Outlook, By Pediococcus (2023-2034) ($MN)
  • Table 9 Global Direct-Fed Microbials (DFM) Market Outlook, By Saccharomyces Cerevisiae (2023-2034) ($MN)
  • Table 10 Global Direct-Fed Microbials (DFM) Market Outlook, By Propionibacterium (2023-2034) ($MN)
  • Table 11 Global Direct-Fed Microbials (DFM) Market Outlook, By Other Types (2023-2034) ($MN)
  • Table 12 Global Direct-Fed Microbials (DFM) Market Outlook, By Form (2023-2034) ($MN)
  • Table 13 Global Direct-Fed Microbials (DFM) Market Outlook, By Powder (2023-2034) ($MN)
  • Table 14 Global Direct-Fed Microbials (DFM) Market Outlook, By Liquid (2023-2034) ($MN)
  • Table 15 Global Direct-Fed Microbials (DFM) Market Outlook, By Capsule (2023-2034) ($MN)
  • Table 16 Global Direct-Fed Microbials (DFM) Market Outlook, By Other Forms (2023-2034) ($MN)
  • Table 17 Global Direct-Fed Microbials (DFM) Market Outlook, By Source (2023-2034) ($MN)
  • Table 18 Global Direct-Fed Microbials (DFM) Market Outlook, By Natural (2023-2034) ($MN)
  • Table 19 Global Direct-Fed Microbials (DFM) Market Outlook, By Synthetic (2023-2034) ($MN)
  • Table 20 Global Direct-Fed Microbials (DFM) Market Outlook, By Formulation (2023-2034) ($MN)
  • Table 21 Global Direct-Fed Microbials (DFM) Market Outlook, By Encapsulated Formulation (2023-2034) ($MN)
  • Table 22 Global Direct-Fed Microbials (DFM) Market Outlook, By Coated Formulation (2023-2034) ($MN)
  • Table 23 Global Direct-Fed Microbials (DFM) Market Outlook, By Blended Formulation (2023-2034) ($MN)
  • Table 24 Global Direct-Fed Microbials (DFM) Market Outlook, By Fermented Formulation (2023-2034) ($MN)
  • Table 25 Global Direct-Fed Microbials (DFM) Market Outlook, By Stabilized Formulation (2023-2034) ($MN)
  • Table 26 Global Direct-Fed Microbials (DFM) Market Outlook, By Other Formulations (2023-2034) ($MN)
  • Table 27 Global Direct-Fed Microbials (DFM) Market Outlook, By Livestock (2023-2034) ($MN)
  • Table 28 Global Direct-Fed Microbials (DFM) Market Outlook, By Ruminants (2023-2034) ($MN)
  • Table 29 Global Direct-Fed Microbials (DFM) Market Outlook, By Cattle (2023-2034) ($MN)
  • Table 30 Global Direct-Fed Microbials (DFM) Market Outlook, By Sheep (2023-2034) ($MN)
  • Table 31 Global Direct-Fed Microbials (DFM) Market Outlook, By Goats (2023-2034) ($MN)
  • Table 32 Global Direct-Fed Microbials (DFM) Market Outlook, By Poultry (2023-2034) ($MN)
  • Table 33 Global Direct-Fed Microbials (DFM) Market Outlook, By Chickens (2023-2034) ($MN)
  • Table 34 Global Direct-Fed Microbials (DFM) Market Outlook, By Ducks (2023-2034) ($MN)
  • Table 35 Global Direct-Fed Microbials (DFM) Market Outlook, By Turkeys (2023-2034) ($MN)
  • Table 36 Global Direct-Fed Microbials (DFM) Market Outlook, By Swine (2023-2034) ($MN)
  • Table 37 Global Direct-Fed Microbials (DFM) Market Outlook, By Aquaculture (2023-2034) ($MN)
  • Table 38 Global Direct-Fed Microbials (DFM) Market Outlook, By Fish (2023-2034) ($MN)
  • Table 39 Global Direct-Fed Microbials (DFM) Market Outlook, By Shrimp (2023-2034) ($MN)
  • Table 40 Global Direct-Fed Microbials (DFM) Market Outlook, By Pets (2023-2034) ($MN)
  • Table 41 Global Direct-Fed Microbials (DFM) Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 42 Global Direct-Fed Microbials (DFM) Market Outlook, By Cats (2023-2034) ($MN)
  • Table 43 Global Direct-Fed Microbials (DFM) Market Outlook, By Horses (2023-2034) ($MN)
  • Table 44 Global Direct-Fed Microbials (DFM) Market Outlook, By Rabbits (2023-2034) ($MN)
  • Table 45 Global Direct-Fed Microbials (DFM) Market Outlook, By Other Livestocks (2023-2034) ($MN)
  • Table 46 Global Direct-Fed Microbials (DFM) Market Outlook, By Application (2023-2034) ($MN)
  • Table 47 Global Direct-Fed Microbials (DFM) Market Outlook, By Stress Management (2023-2034) ($MN)
  • Table 48 Global Direct-Fed Microbials (DFM) Market Outlook, By Antibiotic Alternatives (2023-2034) ($MN)
  • Table 49 Global Direct-Fed Microbials (DFM) Market Outlook, By Weight Gain (2023-2034) ($MN)
  • Table 50 Global Direct-Fed Microbials (DFM) Market Outlook, By Immune Function (2023-2034) ($MN)
  • Table 51 Global Direct-Fed Microbials (DFM) Market Outlook, By Pathogenic Infections (2023-2034) ($MN)
  • Table 52 Global Direct-Fed Microbials (DFM) Market Outlook, By Fiber Digestion (2023-2034) ($MN)
  • Table 53 Global Direct-Fed Microbials (DFM) Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 54 Global Direct-Fed Microbials (DFM) Market Outlook, By End User (2023-2034) ($MN)
  • Table 55 Global Direct-Fed Microbials (DFM) Market Outlook, By Farmers (2023-2034) ($MN)
  • Table 56 Global Direct-Fed Microbials (DFM) Market Outlook, By Pet Owners (2023-2034) ($MN)
  • Table 57 Global Direct-Fed Microbials (DFM) Market Outlook, By Wildlife Rehabilitation Centers (2023-2034) ($MN)
  • Table 58 Global Direct-Fed Microbials (DFM) Market Outlook, By Veterinary Clinics (2023-2034) ($MN)
  • Table 59 Global Direct-Fed Microbials (DFM) Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.